Get startedLog in
    Picture of Lite Strategy logo

    LITS — Lite Strategy News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    All News

    Brief: MEI Pharma, Kyowa Kirin Announce Publication Of Data From Phase 1B Clinical Study Of Zandelisib

    Picture of Lite Strategy logoLite Strategy
    18/07/2022 13:46
    July 18 (Reuters) - Kyowa Kirin Co Ltd  4151.T :
    * MEI PHARMA AND KYOWA KIRIN ANNOUNCE PUBLICATION IN THE
LANCET
ONCOLOGY OF DATA FROM PHASE 1B CLINICAL STUDY OF ZANDELISIB IN
PATIENTS WITH RELAPSED OR REFRACTORY B-CELL MALIGNANCY

Source text for Eikon:  ID:nBwW4m6la 
Further company coverage:  4151.T 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Lite Strategy

    See all news